

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.63767827 |
| 2 | ethanol oxidation (GO:0006069) | 7.39031643 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 7.08482845 |
| 4 | drug catabolic process (GO:0042737) | 7.03135602 |
| 5 | primary alcohol catabolic process (GO:0034310) | 6.91558450 |
| 6 | regulation of fibrinolysis (GO:0051917) | 6.88449304 |
| 7 | regulation of protein activation cascade (GO:2000257) | 6.78824175 |
| 8 | complement activation, alternative pathway (GO:0006957) | 6.74994101 |
| 9 | polyketide metabolic process (GO:0030638) | 6.62201012 |
| 10 | doxorubicin metabolic process (GO:0044598) | 6.62201012 |
| 11 | daunorubicin metabolic process (GO:0044597) | 6.62201012 |
| 12 | ethanol metabolic process (GO:0006067) | 6.60679403 |
| 13 | regulation of complement activation (GO:0030449) | 6.45256134 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.38180062 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 6.38180062 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 6.35420165 |
| 17 | cellular glucuronidation (GO:0052695) | 6.08705127 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.07580322 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 6.07580322 |
| 20 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.86356039 |
| 21 | omega-hydroxylase P450 pathway (GO:0097267) | 5.80372697 |
| 22 | protein carboxylation (GO:0018214) | 5.78723199 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.78723199 |
| 24 | glucuronate metabolic process (GO:0019585) | 5.76569954 |
| 25 | uronic acid metabolic process (GO:0006063) | 5.76569954 |
| 26 | glyoxylate metabolic process (GO:0046487) | 5.73312178 |
| 27 | fibrinolysis (GO:0042730) | 5.72759853 |
| 28 | urea metabolic process (GO:0019627) | 5.66801696 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.18228479 |
| 30 | drug metabolic process (GO:0017144) | 5.06291177 |
| 31 | blood coagulation, intrinsic pathway (GO:0007597) | 5.03201768 |
| 32 | urea cycle (GO:0000050) | 4.91387096 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.88905216 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.88905216 |
| 35 | bile acid biosynthetic process (GO:0006699) | 4.84801090 |
| 36 | axonemal dynein complex assembly (GO:0070286) | 4.82467703 |
| 37 | bile acid metabolic process (GO:0008206) | 4.75093527 |
| 38 | regulation of plasminogen activation (GO:0010755) | 4.55505273 |
| 39 | phenylpropanoid metabolic process (GO:0009698) | 4.51405023 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.40075887 |
| 41 | negative regulation of blood coagulation (GO:0030195) | 4.35620044 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.35620044 |
| 43 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35456367 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 4.33779704 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.32801397 |
| 46 | primary alcohol metabolic process (GO:0034308) | 4.29923483 |
| 47 | acute-phase response (GO:0006953) | 4.27407020 |
| 48 | regulation of humoral immune response (GO:0002920) | 4.24869896 |
| 49 | protein activation cascade (GO:0072376) | 4.24679850 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.23152628 |
| 51 | negative regulation of protein activation cascade (GO:2000258) | 4.21163079 |
| 52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.12594216 |
| 53 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.12594216 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.08996415 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.08996415 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.05699980 |
| 57 | phospholipid efflux (GO:0033700) | 4.03540595 |
| 58 | flavonoid metabolic process (GO:0009812) | 4.02557913 |
| 59 | negative regulation of coagulation (GO:0050819) | 3.98984426 |
| 60 | positive regulation of blood coagulation (GO:0030194) | 3.97798479 |
| 61 | positive regulation of hemostasis (GO:1900048) | 3.97798479 |
| 62 | regulation of apoptotic cell clearance (GO:2000425) | 3.96707040 |
| 63 | complement activation (GO:0006956) | 3.94734878 |
| 64 | regulation of cholesterol esterification (GO:0010872) | 3.92534232 |
| 65 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.92391136 |
| 66 | oxidative demethylation (GO:0070989) | 3.90115742 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 3.88561249 |
| 68 | macromolecular complex remodeling (GO:0034367) | 3.88561249 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.88561249 |
| 70 | negative regulation of wound healing (GO:0061045) | 3.88229961 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.88186875 |
| 72 | negative regulation of humoral immune response (GO:0002921) | 3.87530385 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 3.87282562 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.83613782 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81348096 |
| 76 | cholesterol efflux (GO:0033344) | 3.75737227 |
| 77 | negative regulation of lipase activity (GO:0060192) | 3.71846396 |
| 78 | positive regulation of coagulation (GO:0050820) | 3.68611066 |
| 79 | hormone catabolic process (GO:0042447) | 3.58669503 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.58519278 |
| 81 | negative regulation of complement activation (GO:0045916) | 3.55094809 |
| 82 | progesterone metabolic process (GO:0042448) | 3.53554357 |
| 83 | tyrosine metabolic process (GO:0006570) | 3.50510168 |
| 84 | xenobiotic metabolic process (GO:0006805) | 3.46626081 |
| 85 | glycoside metabolic process (GO:0016137) | 3.45709131 |
| 86 | glycine metabolic process (GO:0006544) | 3.44372258 |
| 87 | retinal metabolic process (GO:0042574) | 3.39277374 |
| 88 | response to mercury ion (GO:0046689) | 3.38678654 |
| 89 | positive regulation of extracellular matrix organization (GO:1903055) | 3.38630956 |
| 90 | acute inflammatory response (GO:0002526) | 3.32581996 |
| 91 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.32264012 |
| 92 | glutamate metabolic process (GO:0006536) | 3.30968419 |
| 93 | cysteine metabolic process (GO:0006534) | 3.29632662 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29285854 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.25066907 |
| 96 | S-adenosylmethionine metabolic process (GO:0046500) | 3.23837897 |
| 97 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.23138219 |
| 98 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.23138219 |
| 99 | cellular aldehyde metabolic process (GO:0006081) | 3.21228472 |
| 100 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.21091406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.64267948 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.64020077 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.13240969 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.76342173 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.69179948 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.67063617 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.23552781 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.79104003 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24751057 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.11884562 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.26776411 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.19313034 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09819601 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00598423 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86985549 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84065492 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.79102644 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70998061 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67850691 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.66299493 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64821972 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59143077 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59112975 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56864114 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52677605 |
| 26 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48245047 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43981953 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39866618 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37196256 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27185894 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26434657 |
| 32 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22621729 |
| 33 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20398256 |
| 34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18556490 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18542261 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15423369 |
| 37 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12970214 |
| 38 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12428077 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09227373 |
| 40 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07476540 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06661996 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02499073 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01931299 |
| 44 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00684445 |
| 45 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98358176 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98105031 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97178383 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96654614 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90497540 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89654827 |
| 51 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89594133 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89282618 |
| 53 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89140112 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88899077 |
| 55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88186926 |
| 56 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86724885 |
| 57 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85059763 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84969790 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84525644 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84236926 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84152146 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81589106 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81342116 |
| 64 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.81290760 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80264586 |
| 66 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79797798 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78887743 |
| 68 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76665752 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76634993 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76327679 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76327679 |
| 72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76086975 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.75991722 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73327885 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73086666 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72958146 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72586241 |
| 78 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.72146134 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71038873 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70465236 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70399959 |
| 82 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.68858798 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68385432 |
| 84 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.67842207 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66833250 |
| 86 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.66830243 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66604771 |
| 88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.65976871 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64953278 |
| 90 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.64933828 |
| 91 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.64443884 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.64028708 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.63947249 |
| 94 | CBP_21632823_ChIP-Seq_H3396_Human | 0.63776748 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62786515 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62713123 |
| 97 | * P68_20966046_ChIP-Seq_HELA_Human | 0.62710697 |
| 98 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.62650750 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.62240001 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61626550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.39623063 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.21424231 |
| 3 | MP0005365_abnormal_bile_salt | 5.56982562 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.35985893 |
| 5 | MP0005360_urolithiasis | 5.26343018 |
| 6 | MP0003195_calcinosis | 3.91848431 |
| 7 | MP0003252_abnormal_bile_duct | 3.34111755 |
| 8 | MP0003868_abnormal_feces_composition | 3.08466571 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.97646129 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.85600417 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.83088572 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.45984572 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.22571894 |
| 14 | MP0009840_abnormal_foam_cell | 2.16918567 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.14340238 |
| 16 | MP0002132_abnormal_respiratory_system | 2.11482101 |
| 17 | MP0005670_abnormal_white_adipose | 2.03700351 |
| 18 | MP0005332_abnormal_amino_acid | 1.91002568 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.88280418 |
| 20 | MP0000609_abnormal_liver_physiology | 1.87319465 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.85102732 |
| 22 | MP0009697_abnormal_copulation | 1.53843337 |
| 23 | MP0001764_abnormal_homeostasis | 1.45836586 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.41961277 |
| 25 | MP0002971_abnormal_brown_adipose | 1.39057332 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.31349637 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.24428351 |
| 28 | MP0005408_hypopigmentation | 1.22417829 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.22233959 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.21977182 |
| 31 | MP0003186_abnormal_redox_activity | 1.18401684 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.16919558 |
| 33 | MP0001661_extended_life_span | 1.15649034 |
| 34 | MP0003690_abnormal_glial_cell | 1.14917335 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.10707425 |
| 36 | MP0005164_abnormal_response_to | 1.09117172 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06570250 |
| 38 | MP0000604_amyloidosis | 1.05864981 |
| 39 | MP0005451_abnormal_body_composition | 1.05570449 |
| 40 | MP0000598_abnormal_liver_morphology | 0.99426153 |
| 41 | MP0004130_abnormal_muscle_cell | 0.98908221 |
| 42 | MP0009763_increased_sensitivity_to | 0.96733815 |
| 43 | MP0004883_abnormal_blood_vessel | 0.95864806 |
| 44 | MP0002168_other_aberrant_phenotype | 0.95073956 |
| 45 | MP0005464_abnormal_platelet_physiology | 0.91004617 |
| 46 | MP0008469_abnormal_protein_level | 0.90526084 |
| 47 | MP0003011_delayed_dark_adaptation | 0.90177992 |
| 48 | MP0001915_intracranial_hemorrhage | 0.89986122 |
| 49 | MP0005375_adipose_tissue_phenotype | 0.88733661 |
| 50 | MP0009115_abnormal_fat_cell | 0.87027171 |
| 51 | MP0003075_altered_response_to | 0.85363523 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.83938922 |
| 53 | MP0005334_abnormal_fat_pad | 0.82648597 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.82074410 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 0.81893280 |
| 56 | MP0005023_abnormal_wound_healing | 0.81200150 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 0.80536683 |
| 58 | MP0000566_synostosis | 0.78485666 |
| 59 | MP0000858_altered_metastatic_potential | 0.78245497 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 0.76403572 |
| 61 | MP0000249_abnormal_blood_vessel | 0.76093217 |
| 62 | MP0009053_abnormal_anal_canal | 0.73304160 |
| 63 | MP0005395_other_phenotype | 0.70182884 |
| 64 | MP0005535_abnormal_body_temperature | 0.69891814 |
| 65 | MP0002909_abnormal_adrenal_gland | 0.69158581 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.63988444 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.63012909 |
| 68 | MP0009785_altered_susceptibility_to | 0.60972872 |
| 69 | MP0002970_abnormal_white_adipose | 0.60893331 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 0.60118456 |
| 71 | MP0003303_peritoneal_inflammation | 0.60026636 |
| 72 | MP0004043_abnormal_pH_regulation | 0.59992708 |
| 73 | MP0005083_abnormal_biliary_tract | 0.57183267 |
| 74 | MP0003959_abnormal_lean_body | 0.57016836 |
| 75 | MP0009764_decreased_sensitivity_to | 0.56631348 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.55394633 |
| 77 | MP0003828_pulmonary_edema | 0.54920181 |
| 78 | MP0002282_abnormal_trachea_morphology | 0.54872498 |
| 79 | MP0002249_abnormal_larynx_morphology | 0.53770718 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.53185539 |
| 81 | MP0003436_decreased_susceptibility_to | 0.53114228 |
| 82 | MP0003879_abnormal_hair_cell | 0.52593575 |
| 83 | MP0002419_abnormal_innate_immunity | 0.51248375 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.50766586 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.50341464 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.50072299 |
| 87 | MP0005166_decreased_susceptibility_to | 0.48800010 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.47948715 |
| 89 | MP0005448_abnormal_energy_balance | 0.47200903 |
| 90 | MP0003329_amyloid_beta_deposits | 0.46144508 |
| 91 | MP0001851_eye_inflammation | 0.44370991 |
| 92 | MP0005409_darkened_coat_color | 0.43692187 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.43238041 |
| 94 | MP0005647_abnormal_sex_gland | 0.42766078 |
| 95 | MP0005165_increased_susceptibility_to | 0.41632613 |
| 96 | MP0002653_abnormal_ependyma_morphology | 0.41363284 |
| 97 | MP0008874_decreased_physiological_sensi | 0.41260688 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.40362594 |
| 99 | MP0005025_abnormal_response_to | 0.40018133 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.38980113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.65697606 |
| 2 | Deep venous thrombosis (HP:0002625) | 8.15904856 |
| 3 | Complement deficiency (HP:0004431) | 7.74019658 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.56841010 |
| 5 | Abnormality of complement system (HP:0005339) | 6.40625442 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.27274731 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.95357845 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.88037143 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.59330096 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.22358284 |
| 11 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.16576438 |
| 12 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.16576438 |
| 13 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.09532843 |
| 14 | Joint hemorrhage (HP:0005261) | 5.03970922 |
| 15 | Abnormal ciliary motility (HP:0012262) | 4.91684969 |
| 16 | Absent/shortened dynein arms (HP:0200106) | 4.89993650 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.89993650 |
| 18 | Rhinitis (HP:0012384) | 4.88229827 |
| 19 | Glomerulonephritis (HP:0000099) | 4.85540656 |
| 20 | Xanthomatosis (HP:0000991) | 4.33152961 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 4.24453544 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.19961859 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.98470859 |
| 24 | Intrahepatic cholestasis (HP:0001406) | 3.97419591 |
| 25 | Chronic bronchitis (HP:0004469) | 3.63897369 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.59528684 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.45215082 |
| 28 | Nephritis (HP:0000123) | 3.42427525 |
| 29 | Spontaneous abortion (HP:0005268) | 3.37649475 |
| 30 | Fat malabsorption (HP:0002630) | 3.35829451 |
| 31 | Nasal polyposis (HP:0100582) | 3.34940335 |
| 32 | Bronchiectasis (HP:0002110) | 3.31763531 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.18281754 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.18068746 |
| 35 | Rickets (HP:0002748) | 3.12765588 |
| 36 | Vascular calcification (HP:0004934) | 3.11735330 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.08430065 |
| 38 | Purpura (HP:0000979) | 3.00585598 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.91694147 |
| 40 | Mitral stenosis (HP:0001718) | 2.90489100 |
| 41 | Steatorrhea (HP:0002570) | 2.90182312 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86420643 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.76465095 |
| 44 | Myocardial infarction (HP:0001658) | 2.69102319 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.62603967 |
| 46 | Gingival bleeding (HP:0000225) | 2.61797252 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.50836824 |
| 48 | Epidermoid cyst (HP:0200040) | 2.46911783 |
| 49 | Hyperammonemia (HP:0001987) | 2.37144856 |
| 50 | Bifid scrotum (HP:0000048) | 2.33663466 |
| 51 | Recurrent sinusitis (HP:0011108) | 2.32399452 |
| 52 | Amyloidosis (HP:0011034) | 2.30690326 |
| 53 | Osteomalacia (HP:0002749) | 2.26715185 |
| 54 | Recurrent otitis media (HP:0000403) | 2.24913407 |
| 55 | Thrombophlebitis (HP:0004418) | 2.19526240 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.17340719 |
| 57 | Menorrhagia (HP:0000132) | 2.13071087 |
| 58 | Hypertriglyceridemia (HP:0002155) | 2.09888252 |
| 59 | Skin nodule (HP:0200036) | 2.03505008 |
| 60 | Infertility (HP:0000789) | 2.02507443 |
| 61 | Bronchitis (HP:0012387) | 2.02173614 |
| 62 | Pulmonary embolism (HP:0002204) | 2.01697921 |
| 63 | Increased serum ferritin (HP:0003281) | 1.98670038 |
| 64 | Abnormality of methionine metabolism (HP:0010901) | 1.93291775 |
| 65 | Male infertility (HP:0003251) | 1.92661432 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 1.91520616 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 1.87742038 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87068686 |
| 69 | Hyperbilirubinemia (HP:0002904) | 1.86169003 |
| 70 | Delayed CNS myelination (HP:0002188) | 1.85898648 |
| 71 | Hyperglycinemia (HP:0002154) | 1.83721222 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 1.82397601 |
| 73 | Abnormality of vitamin metabolism (HP:0100508) | 1.77689196 |
| 74 | Hypophosphatemic rickets (HP:0004912) | 1.74034452 |
| 75 | Back pain (HP:0003418) | 1.73754231 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 1.67936338 |
| 77 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67936338 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.64162927 |
| 79 | Mucopolysacchariduria (HP:0008155) | 1.64162927 |
| 80 | Gangrene (HP:0100758) | 1.62819035 |
| 81 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60217280 |
| 82 | Joint swelling (HP:0001386) | 1.58395633 |
| 83 | Elevated alkaline phosphatase (HP:0003155) | 1.56592746 |
| 84 | Chronic sinusitis (HP:0011109) | 1.55897055 |
| 85 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.55624371 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 1.53888366 |
| 87 | Hydroxyprolinuria (HP:0003080) | 1.53888366 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 1.53185831 |
| 89 | Polycythemia (HP:0001901) | 1.52532054 |
| 90 | Abnormality of carpal bone ossification (HP:0006257) | 1.51357163 |
| 91 | Polygenic inheritance (HP:0010982) | 1.50388254 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.50106405 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.50106405 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.50106405 |
| 95 | Hyperglycinuria (HP:0003108) | 1.50029078 |
| 96 | Epistaxis (HP:0000421) | 1.49001564 |
| 97 | Atelectasis (HP:0100750) | 1.48957615 |
| 98 | Increased mean platelet volume (HP:0011877) | 1.48947645 |
| 99 | Flat acetabular roof (HP:0003180) | 1.48076300 |
| 100 | Metabolic acidosis (HP:0001942) | 1.45855719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.71375416 |
| 2 | ERN1 | 3.82643619 |
| 3 | FGFR4 | 3.13968067 |
| 4 | TRIB3 | 2.96205084 |
| 5 | RIPK1 | 2.80074922 |
| 6 | EPHA2 | 2.76303812 |
| 7 | MAP3K3 | 2.12002573 |
| 8 | ICK | 2.09112824 |
| 9 | IRAK3 | 1.98958437 |
| 10 | MAP3K2 | 1.94677030 |
| 11 | MST1R | 1.89940421 |
| 12 | TBK1 | 1.84975837 |
| 13 | TYK2 | 1.81784757 |
| 14 | MAPKAPK3 | 1.78298689 |
| 15 | FGFR3 | 1.75487046 |
| 16 | RIPK4 | 1.71870144 |
| 17 | PRKAA2 | 1.67354828 |
| 18 | SMG1 | 1.58371141 |
| 19 | EEF2K | 1.58218901 |
| 20 | CSK | 1.53302749 |
| 21 | NEK9 | 1.48018421 |
| 22 | PRPF4B | 1.47314571 |
| 23 | SIK1 | 1.46804063 |
| 24 | PDPK1 | 1.40383520 |
| 25 | TGFBR2 | 1.35764614 |
| 26 | EPHA3 | 1.30153274 |
| 27 | CDK6 | 1.26108045 |
| 28 | EPHB1 | 1.25902665 |
| 29 | MST4 | 1.22753466 |
| 30 | ZAP70 | 1.22516922 |
| 31 | ABL2 | 1.19630853 |
| 32 | DDR2 | 1.12729642 |
| 33 | MAP3K13 | 1.10320921 |
| 34 | LATS1 | 1.04432603 |
| 35 | MAPK11 | 1.04064171 |
| 36 | LATS2 | 1.01998088 |
| 37 | MAP3K6 | 1.00996769 |
| 38 | PRKACG | 0.99257926 |
| 39 | MYLK | 0.96070123 |
| 40 | TRPM7 | 0.94825213 |
| 41 | MAP2K3 | 0.94761735 |
| 42 | STK38 | 0.89352448 |
| 43 | TESK1 | 0.88079748 |
| 44 | CDC42BPA | 0.86907583 |
| 45 | LRRK2 | 0.86618488 |
| 46 | DYRK1B | 0.86463611 |
| 47 | ERBB4 | 0.85785126 |
| 48 | MAP3K7 | 0.84854742 |
| 49 | MAP2K4 | 0.82910257 |
| 50 | MAP3K1 | 0.77431235 |
| 51 | KSR2 | 0.76978252 |
| 52 | PDGFRA | 0.76884888 |
| 53 | MARK2 | 0.75541414 |
| 54 | PDK1 | 0.74520397 |
| 55 | ERBB2 | 0.74152061 |
| 56 | PIK3CG | 0.73546147 |
| 57 | RET | 0.73325767 |
| 58 | IGF1R | 0.72638817 |
| 59 | BLK | 0.72305418 |
| 60 | JAK1 | 0.68973410 |
| 61 | CAMKK2 | 0.66599042 |
| 62 | CDK12 | 0.66525119 |
| 63 | ARAF | 0.64432100 |
| 64 | MAPK12 | 0.63791238 |
| 65 | STK24 | 0.63382725 |
| 66 | MET | 0.62087774 |
| 67 | STK10 | 0.61092680 |
| 68 | JAK2 | 0.61050364 |
| 69 | PKN2 | 0.60002550 |
| 70 | MAP3K12 | 0.55189272 |
| 71 | MAP3K14 | 0.54095844 |
| 72 | PTK6 | 0.53427754 |
| 73 | CSF1R | 0.52931813 |
| 74 | YES1 | 0.52915784 |
| 75 | GRK6 | 0.52373871 |
| 76 | MAP3K11 | 0.52363731 |
| 77 | PAK4 | 0.52109625 |
| 78 | PRKAA1 | 0.50775180 |
| 79 | SRC | 0.48845626 |
| 80 | CAMKK1 | 0.48760773 |
| 81 | PDGFRB | 0.47314662 |
| 82 | NLK | 0.46361529 |
| 83 | FER | 0.44985897 |
| 84 | CDK4 | 0.43721706 |
| 85 | CAMK1D | 0.43268705 |
| 86 | TIE1 | 0.42297908 |
| 87 | GSK3A | 0.42105969 |
| 88 | PRKG1 | 0.41258258 |
| 89 | SGK1 | 0.40906686 |
| 90 | MTOR | 0.40725868 |
| 91 | IRAK1 | 0.40712045 |
| 92 | MAPK4 | 0.39551463 |
| 93 | MAPK7 | 0.38203822 |
| 94 | PRKCZ | 0.37317843 |
| 95 | PTK2 | 0.36478715 |
| 96 | KIT | 0.33976689 |
| 97 | ABL1 | 0.33290267 |
| 98 | PRKCD | 0.33072543 |
| 99 | SGK3 | 0.32242787 |
| 100 | TAOK2 | 0.31588636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.73520103 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.71719866 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.70122978 |
| 4 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.56992261 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.53208920 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44996008 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.37117449 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.33303826 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.22711238 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13620290 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.02736931 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.77571426 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.76367627 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.61395720 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54209836 |
| 16 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.38401889 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08273157 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07964428 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81734282 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.77254714 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76281080 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76088496 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73069692 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71291842 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.67931204 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57878335 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45495149 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.36431207 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36213401 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28419079 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26734590 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.25781923 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06866825 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04869342 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04150851 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03953113 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.99068133 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98758858 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92703999 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 0.89563785 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87517573 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87453249 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87092888 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83994422 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79399531 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78516391 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74729405 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72944148 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71494726 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69430189 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68900831 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68037648 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67987911 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67691836 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61272738 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57723504 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56474768 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49882710 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.45166793 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.42977466 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42100532 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40470235 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37294982 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36417756 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35059464 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.33020112 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.31014119 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29177942 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28087224 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24473489 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23218439 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22261577 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21550874 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11811850 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11438652 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11401356 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10220307 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09650237 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.09421159 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.09193325 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.08065946 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.07876786 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05568462 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00911402 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00294815 |
| 86 | Phagosome_Homo sapiens_hsa04145 | -0.1723856 |
| 87 | Malaria_Homo sapiens_hsa05144 | -0.1722721 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1654989 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1620694 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1480654 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1324920 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.1221824 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1207245 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1095802 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.0896186 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0518886 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0357270 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0282352 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.0133188 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0119597 |

